We are live on
!
Find out more
BIA
Biondo Investment Advisors Portfolio holdings
AUM
$780M
1-Year Est. Return
21.03%
This Fund
S&P 500
This Quarter
Est. Return
+14.71%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.27%
AUM
$522M
AUM Growth
+$60.6M
(+13%)
Cap. Flow
+$753K
Cap. Flow
% of AUM
0.14%
Top 10 Holdings %
Top 10 Hldgs %
49.43%
Holding
88
New
5
Increased
42
Reduced
31
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Simon Property Group
SPG
|
+$3.1M |
| 2 |
Starbucks
SBUX
|
+$2.33M |
| 3 |
Illinois Tool Works
ITW
|
+$1.97M |
| 4 |
Automatic Data Processing
ADP
|
+$1.96M |
| 5 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$1.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$9.91M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$1.88M |
| 3 |
Microsoft
MSFT
|
+$1.31M |
| 4 |
Apple
AAPL
|
+$1.17M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$716K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.24% |
| 2 | Technology | 22.81% |
| 3 | Financials | 10.41% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Communication Services | 4.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Boston Omaha
BOC
$436M
| $304K | 0.06% |
+11,000
| New | +$224K |
|
77
Pacira BioSciences
PCRX
$997M
| $238K | 0.05% |
3,975
-25
| -0.6% | -$1.46K |
|
78
Invesco QQQ Trust
QQQ
$484B
| $235K | 0.05% |
750
| – | – |
|
79
10x Genomics
TXG
$6.61B
| $234K | 0.04% |
+1,650
| New | +$239K |
|
80
iShares Core S&P US Growth ETF
IUSG
$33.7B
| $231K | 0.04% |
2,606
-145
| -5% | -$12.2K |
|
81
iShares Core MSCI EAFE ETF
IEFA
$196B
| $209K | 0.04% |
+3,029
| New | +$196K |
|
|
MCI
82
Barings Corporate Investors
MCI
$345M
| $198K | 0.04% |
15,000
| – | – |
|
83
Energy Transfer Partners
ET
$69.3B
| $174K | 0.03% |
23,460
| – | – |
|
|
LBAI
84
DELISTED
Lakeland Bancorp Inc
LBAI
| $140K | 0.03% |
11,000
| – | – |
|
|
BNY
85
Bank of New York Mellon
BNY
$107B
| – | – |
-8,229
| Closed | -$283K |
|
|
86
Regeneron Pharmaceuticals
REGN
$80.8B
| – | – |
-3,350
| Closed | -$1.88M |
|
87
ProShares UltraShort S&P500
SDS
$390M
| – | – |
-600
| Closed | -$239K |
|
Similar funds
LA
SG
RTM
QCMNJ
TIS
MO
NCM
PC
Biondo Investment Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Biondo Investment Advisors held 88 positions worth $522M, up 13% from $461M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Biondo Investment Advisors's Q4 2020 filing shows 5 new, 42 increased, 31 reduced and 3 closed positions. Its largest new stake was Simon Property Group: 40,654 shares worth $3.47M. The largest sale was Block Inc, an estimated $9.91M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 36% a quarter earlier, followed by Technology and Financials.
- Biondo Investment Advisors's largest Q4 2020 buy was Simon Property Group: 40,654 shares worth $3.47M.
- Biondo Investment Advisors added most to Starbucks in Q4 2020, an estimated $2.33M increase.
- Biondo Investment Advisors's biggest Q4 2020 reduction was Block Inc, cutting an estimated $9.91M.
- Biondo Investment Advisors fully exited Regeneron Pharmaceuticals in Q4 2020, selling an estimated $1.88M.
- Biondo Investment Advisors's ten largest holdings make up 49% of its $522M portfolio in Q4 2020.
- Biondo Investment Advisors opened 5 new positions and closed 3 in Q4 2020.
- Biondo Investment Advisors's portfolio value rose 13% quarter-over-quarter to $522M.
Based on Biondo Investment Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.